Most melanomas don’t actually start in existing moles. A large meta-analysis covering more than 20,000 melanomas found that about 71% developed as entirely new growths on the skin, while only 29% arose from a pre-existing mole. Still, the biological process behind both paths is the same: DNA damage accumulates in pigment-producing skin cells called melanocytes, key protective genes stop working, and the immune system eventually loses its ability to keep abnormal cells in check.
What UV Radiation Does to Skin Cells
Ultraviolet radiation from the sun or tanning beds is the primary driver. When UV light hits melanocytes, it creates specific types of DNA damage, most importantly fused segments in the DNA strand that the cell then has to repair. UV also generates reactive oxygen species, unstable molecules that cause additional DNA damage indirectly. If the cell can repair this damage correctly, no harm done. But with repeated UV exposure over years, repair errors pile up.
Healthy cells have a built-in safety net. A protein called p53, sometimes called the “guardian of the genome,” detects DNA damage and forces the cell to pause its growth cycle so repairs can happen. If the damage is too severe, p53 triggers the cell to self-destruct rather than pass on broken DNA. But UV radiation can knock out p53 itself. When that happens, damaged cells keep dividing instead of stopping or dying, and mutations accumulate much faster.
The Mutations That Drive the Shift
One genetic change stands out. Between 40% and 60% of melanomas carry a mutation in a gene called BRAF, which controls a major growth-signaling pathway. The most common version of this mutation, found in roughly 90% of BRAF-mutated melanomas, acts like a stuck accelerator pedal: it tells the cell to keep growing nonstop.
Here’s where it gets counterintuitive. That same BRAF mutation is found at similarly high rates (62% to 72%) in completely benign moles. In normal cells, an overactive growth signal actually triggers a protective response. The cell recognizes something is wrong and enters a permanent state of dormancy called senescence. This is why most moles with a BRAF mutation simply stop growing and stay harmless for life.
The trouble begins when additional mutations disable these backup brakes. If p53 is lost, or if another tumor-suppressing pathway is knocked out, the cell can override senescence and start proliferating without limits. Research has identified a specific signaling chain involving a receptor on melanocytes that normally suppresses a pro-growth pathway after UV exposure. People with certain genetic variants of this receptor are defective at activating that suppression, which means UV exposure more easily pushes their melanocytes toward uncontrolled growth. This helps explain why fair-skinned individuals with red hair, who commonly carry these receptor variants, face higher melanoma risk.
How the Immune System Holds the Line
Even after a cell accumulates dangerous mutations, the immune system provides another layer of defense. Immune cells, particularly certain white blood cells, constantly patrol the body looking for cells that display abnormal surface markers. When they find a transformed cell, they can kill it directly by puncturing its membrane. This process, called immune surveillance, eliminates most precancerous cells before they ever become a problem.
Cancer researchers now describe this interaction as a three-phase process. First comes elimination, where immune cells successfully destroy abnormal cells. If some survive, the process enters equilibrium: the immune system can’t wipe out the abnormal cells entirely, but it keeps them contained, sometimes for years. During this dormant phase, though, the surviving cells continue to mutate. Eventually, some variants emerge that can suppress or hide from immune responses. That’s the escape phase, when the immune system loses control and a tumor begins growing visibly.
Anything that weakens immune function, whether medications that suppress the immune system, chronic illness, or aging, can shorten the equilibrium phase and give abnormal cells a faster path to escape.
Why More Moles Means More Risk
The total number of moles on your body is one of the strongest predictors of melanoma risk. An Australian study found that each additional mole increases risk by about 2%. That adds up quickly: people in the top 20% for mole count had roughly 7.6 times the melanoma risk compared to those in the bottom 20%. For a specific subtype of flat, uniformly colored moles, the risk ratio was even higher, reaching about 11 times in the highest count group.
This doesn’t mean each individual mole is dangerous. Rather, a high mole count signals that your melanocytes are more active and genetically prone to proliferation, which creates more opportunities for the kind of mutation pileup described above. It’s a marker of underlying biology, not a collection of individual threats.
What a Changing Mole Looks Like
The National Cancer Institute recommends watching for five features, known by the acronym ABCDE:
- Asymmetry: one half of the mole doesn’t mirror the other
- Border irregularity: edges that are ragged, notched, or blurred, sometimes with pigment spreading into surrounding skin
- Color variation: uneven shades of brown, black, or tan, or unexpected colors like white, red, pink, or blue within the same spot
- Diameter: growth to larger than about 6 millimeters (roughly the size of a pencil eraser), though melanomas can be smaller
- Evolving: any noticeable change in size, shape, or color over weeks or months
Dermatologists also use a magnifying tool called a dermatoscope to look for deeper patterns invisible to the naked eye. Certain vascular patterns, including corkscrew-shaped or irregularly distributed blood vessels within a lesion, are highly suggestive of malignancy. In some melanomas that produce little or no pigment, these abnormal blood vessel patterns may be the only visible clue.
Melanomas From Existing Moles vs. New Spots
The fact that roughly 71% of melanomas appear as new growths rather than transforming from existing moles carries a practical implication. You should pay attention not just to moles you’ve always had, but to any new spot that appears on your skin, especially after age 30, when new benign moles become less common. The “ugly duckling” approach is useful here: look for any spot that simply doesn’t match the rest of your moles in color, size, or shape.
There is a silver lining for the 29% that do arise from existing moles. These tend to be caught at a thinner stage, likely because people notice changes in a familiar spot sooner than they notice an entirely new one. Thinner melanomas generally carry a better prognosis because they haven’t had time to grow deeper into the skin or spread.
Does Removing Moles Prevent Cancer?
Prophylactic removal of ordinary moles is not a standard prevention strategy. Since the vast majority of melanomas arise as new growths, removing existing benign moles wouldn’t meaningfully reduce your overall risk. The exception involves people with rare genetic syndromes that produce atypical moles at high rates. For these individuals, dermatologists may recommend removing changing lesions along with skin checks every six months.
For everyone else, the most effective approach is monitoring. Sequential digital dermoscopy, where a dermatologist photographs suspicious lesions and compares them over intervals of 3 to 12 months, has been shown to improve early detection of primary melanomas in high-risk individuals. Combined with consistent sun protection to reduce cumulative UV damage, this surveillance approach targets the actual mechanism: catching the transition early rather than trying to preemptively remove every potential site.